Loading...
Kinase inhibitors developed for treatment of hematologic malignancies: implications for immune modulation in COVID-19
Tyrosine kinase inhibitors (TKIs) are used to target dysregulated signaling pathways in virtually all hematologic malignancies. Many of the targeted signaling pathways are also essential in nonmalignant immune cells. The current coronavirus severe acute respiratory syndrome coronavirus 2 pandemic ca...
Na minha lista:
| Udgivet i: | Blood Adv |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Hematology
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7871903/ https://ncbi.nlm.nih.gov/pubmed/33560402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020003768 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|